Vaxart Stock Analysis

VXRT
 Stock
  

USD 1.23  0.06  5.13%   

The big decline in price over the last few months for Vaxartmay raise some interest from private investors as it is trading at a share price of 1.23 on 1,872,901 in trading volume. The company executives failed to add value to investors and position the company supply of money to exploit market volatility in November. However, diversifying your holdings with Vaxart Inc or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.12. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Vaxart Inc partners.
Also, please take a look at World Market Map.
  
The Vaxart stock analysis report makes it easy to digest most publicly released information about Vaxart and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Vaxart Stock analysis module also helps to analyze the Vaxart price relationship with some important fundamental indicators such as market cap and management efficiency.

Vaxart Stock Analysis Notes

About 40.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.32. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vaxart Inc recorded a loss per share of 0.64. The entity last dividend was issued on the 9th of November 2012. The firm had 1:11 split on the 14th of February 2018. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 110 people. For more information please call Cezar MBA at 650 550 3500 or visit https://vaxart.com.

Vaxart Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vaxart's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vaxart Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vaxart Inc generated a negative expected return over the last 90 days
Vaxart Inc has high historical volatility and very poor performance
Vaxart Inc may become a speculative penny stock
The company reported the previous year's revenue of 892 K. Net Loss for the year was (70.47 M) with loss before overhead, payroll, taxes, and interest of (47.86 M).
Vaxart Inc currently holds about 129.55 M in cash with (59.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.

Vaxart Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 153.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaxart's market, we take the total number of its shares issued and multiply it by Vaxart's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (0.3141) % which means that it has lost $0.3141 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.6393) %, meaning that it created substantial loss on money invested by shareholders. Vaxart management efficiency ratios could be used to measure how well vaxart inc manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 2nd of December, Vaxart has the risk adjusted performance of (0.37), and Coefficient Of Variation of (398.23). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaxart Inc, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Vaxart Inc, which can be compared to its competition. Please validate Vaxart Inc market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Vaxart is priced more or less accurately, providing market reflects its prevalent price of 1.23 per share. Given that Vaxart Inc is a hitting penny stock territory we recommend to closely look at its total risk alpha.

Vaxart Inc Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vaxart middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vaxart Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
.

Vaxart Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaxart insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaxart's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaxart insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vaxart Technical and Predictive Indicators

Vaxart Forecast Models

Vaxart time-series forecasting models is one of many Vaxart's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vaxart's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Vaxart Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vaxart prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vaxart shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Vaxart. By using and applying Vaxart Stock analysis, traders can create a robust methodology for identifying Vaxart entry and exit points for their positions.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 110 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vaxart to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module
Also, please take a look at World Market Map. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for analysis

When running Vaxart Inc price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Is Vaxart's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxart. If investors know Vaxart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxart listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
153.6 M
Quarterly Revenue Growth YOY
(0.83) 
Return On Assets
(0.31) 
Return On Equity
(0.64) 
The market value of Vaxart Inc is measured differently than its book value, which is the value of Vaxart that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine Vaxart value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.